Neurobehavioral Mechanisms in Depression and Anxiety Disorders

Depression and anxiety disorders arise from complex interactions between neural circuits, molecular signalling and environmental stressors. Key limbic structures—such as the amygdala, hippocampus and prefrontal cortex—mediate emotional processing, memory and executive control. Dysregulation of the hypothalamic–pituitary–adrenal axis under chronic stress leads to sustained release of glucocorticoids, which in turn promotes neuroinflammatory responses. Activated microglia release pro-inflammatory cytokines that disrupt synaptic plasticity and neurogenesis, compromising resilience to stress. Concurrently, alterations in neurotrophic factors, notably brain-derived neurotrophic factor (BDNF), impair synaptic connectivity and neuronal survival. Genetic and epigenetic variation modulates expression of key regulators—such as phosphodiesterase-4D (PDE4D) and mitogen-activated protein kinase phosphatase-1 (MKP-1)—thereby influencing intracellular cyclic AMP and MAPK signalling. Recent advances in optogenetics and in vivo imaging have revealed how aberrant circuit dynamics contribute to behavioural despair, anhedonia and heightened vigilance. These mechanistic insights point towards novel intervention targets, including neuromodulation of cholinergic anti-inflammatory pathways, restoration of neurotrophic support and modulation of intracellular kinase cascades. Understanding these interwoven processes offers a path to more precise, mechanism-based therapies for mood and anxiety disorders.

Research from Nature Portfolio

Experimental knock-down of long-form PDE4D isoforms in the prefrontal cortex of chronically stressed rodents restored intracellular cyclic AMP–PKA–CREB and ERK–CREB signalling, reversed corticosterone elevation, and alleviated both depressive-like behaviour and memory deficits. These findings identify PDE4D4 and PDE4D5 as critical regulators of stress-induced synaptic plasticity and highlight cyclic AMP degradation as a therapeutic target in major depression.

Neurobehavioral Mechanisms in Depression and Anxiety Disorders publication trend

The graph below shows the total number of articles in neurobehavioral mechanisms in depression and anxiety disorders across all publications each year (not limited to Nature Index journals).

Technical terms

Neuroinflammation: Immune activation within the brain, involving microglial release of cytokines, which can impair synaptic function and mood regulation.

Microglia: The resident immune cells of the central nervous system that respond to stress or injury by modulating synaptic architecture and inflammatory signalling.

Brain-derived neurotrophic factor (BDNF): A protein critical for neuronal survival, dendritic growth and synaptic plasticity, often reduced in mood disorders.

Phosphodiesterase-4D (PDE4D): An enzyme that degrades cyclic AMP, thereby modulating intracellular signalling cascades linked to mood, cognition and neuroplasticity.

α7 Nicotinic acetylcholine receptor (α7nAChR): A ligand-gated ion channel that mediates cholinergic anti-inflammatory signalling and influences neuroimmune interactions relevant to depression.

References

1. Major Depression: One Brain, One Disease, One Set of Intertwined Processes. Cells (2021).
2. Phosphodiesterase-4D Knock-down in the Prefrontal Cortex Alleviates Chronic Unpredictable Stress-Induced Depressive-Like Behaviors and Memory Deficits in Mice. Scientific Reports (2015).
3. An ancient polymorphic regulatory region within the BDNF gene associated with obesity modulates anxiety-like behaviour in mice and humans. Molecular Psychiatry (2024).
4. Down-regulation of MKP-1 in hippocampus protects against stress-induced depression-like behaviors and neuroinflammation. Translational Psychiatry (2024).
5. α7 Nicotinic acetylcholine receptor: a key receptor in the cholinergic anti-inflammatory pathway exerting an antidepressant effect. Journal of Neuroinflammation (2023).